Collection's Items (Sorted by Issue Date in Descending order): 81 to 100 of 918
Preview | Issue Date | Title | Author(s) |
| 2017 | Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis | Costello, S.; Soo, W.; Bryant, R.; Jairath, V.; Hart, A.; Andrews, J. |
| 2017 | Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis | Williams, B.; Tsangari, E.; Stansborough, R.; Marino, V.; Cantley, M.; Dharmapatni, A.; Gibson, R.; Perilli, E.; Crotti, T. |
| 2017 | Advances in drug metabolism and pharmacogenetics research in Australia | Mackenzie, P.; Somogyi, A.; Miners, J. |
| 2017 | Filterability of human serum albumin in parenteral nutrition administered to neonates through an in-line 0.2 micron filter | Prosser, A.E.; Wynne, S.B.; Morris, S.A.; Grzeskowiak, L.E. |
| 2017 | A brief pictorial and historical introduction to guaiacum – from a putative cure for syphilis to an actual screening method for colorectal cancer | Eppenberger, P.; Galassi, F.; Rühli, F. |
| 2017 | Constriction of the buccal branch of the facial nerve produces unilateral craniofacial allodynia | Lewis, S.; Grace, P.; Hutchinson, M.; Maier, S.; Watkins, L. |
| 2017 | Sensitive cytokine assay based on optical fiber allowing localized and spatially resolved detection of interleukin-6 | Liu, G.; Zhang, K.; Nadort, A.; Hutchinson, M.; Goldys, E. |
| 2016 | Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users | McKetin, R.; Gardner, J.; Baker, A.; Dawe, S.; Ali, R.; Voce, A.; Leach, L.; Lubman, D.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 2 Nov 2016 : Sydney, Australia) |
| 2016 | Psychosocial interventions for cannabis use disorder | Gates, P.; Sabioni, P.; Copeland, J.; Le Foll, B.; Gowing, L.; Australasian Professional Society on Alcohol and other Drugs Conference 2016 (30 Oct 2016 - 2 Nov 2016 : Sydney, Australia) |
| 2016 | Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims database | Wahab, I.A.; Pratt, N.L.; Ellett, L.K.; Roughead, E.E. |
| 2016 | Authors’ reply to Palozzo and Messori: ‘‘Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review’’ | Parkinson, B.; Elshaug, A.G. |
| 2016 | Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities | Philpott, H.; Nandurkar, S.; Royce, S.; Thien, F.; Gibson, P. |
| 2016 | A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis | Philpott, H.; Nandurkar, S.; Royce, S.; Thien, F.; Gibson, P. |
| 2016 | Therapeutic drug monitoring of everolimus: a consensus report | Shipkova, M.; Hesselink, D.; Holt, D.; Billaud, E.; Van Gelder, T.; Kunicki, P.; Brunet, M.; Budde, K.; Barten, M.; De Simone, P.; Wieland, E.; Lopez, O.; Masuda, S.; Seger, C.; Picard, N.; Oellerich, M.; Langman, L.; Wallemacq, P.; Morris, R.; Thompson, C.; et al. |
| 2016 | Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta | Ng, H.H.; Leo, C.H.; Parry, L.J. |
| 2016 | Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression | Loo, C.; Gálvez, V.; O'Keefe, E.; Mitchell, P.; Hadzi-Pavlovic, D.; Leyden, J.; Harper, S.; Somogyi, A.; Lai, R.; Weickert, C.; Glue, P. |
| 2016 | Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia | Larance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.; Wilkinson, C.; Livingston, M. |
| 2016 | Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity | Das, S.; Stark, L.; Musgrave, I.; Pukala, T.; Smid, S. |
| 2016 | A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity | Wojciechowski, J.; Wiese, M.; Proudman, S.; Foster, D.; Upton, R. |
| 2016 | Serelaxin: a novel therapeutic for vascular diseases | Leo, C.H.; Jelinic, M.; Ng, H.H.; Tare, M.; Parry, L.J. |
Collection's Items (Sorted by Issue Date in Descending order): 81 to 100 of 918